A single-nucleotide polymorphism of miR-196a-2 and vitiligo: An association study and functional analysis in a Han Chinese population

Pigment Cell and Melanoma Research

Volumn 26, Issue 3, 2013, Pages 338-347

  Huang, Ye ^a,b,c   Yi, Xiuli ^a   Jian, Zhe ^a   Wei, Chao ^a   Li, Shuli ^a   Cai, Chuan ^a,b   Zhang, Ping ^b   Li, Kai ^a   Guo, Sen ^a   Liu, Ling ^a   Shi, Qiong ^a   Gao, Tianwen ^a   Li, Chunying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c INSTITUTE OF AVIATION MEDICINE   (China)

Author keywords

MiR 196a 2; Oxidative stress; SNP; TYRP1; Vitiligo

Indexed keywords

MICRORNA; MICRORNA 196A 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ALLELE; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL VIABILITY; CHINESE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; MALE; MELANOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

ADULT; APOPTOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CELL SURVIVAL; CHINA; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SPACE; MALE; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MICRORNAS; MODELS, GENETIC; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES; VITILIGO;

EID: 84876811026     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12081     Document Type: Article

References (45)

1. Alkhateeb, A., Fain, P.R., Thody, A., Bennett, D.C., and Spritz, R.A. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16, 208-214.
2. Arcos-Burgos, M., Parodi, E., Salgar, M. et al. (2002). Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110, 334-342.
3. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Bickers, D.R., and Athar, M. (2006). Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 126, 2565-2575.
5. Birlea, S.A., Jin, Y., Bennett, D.C. et al. (2011). Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J. Invest. Dermatol. 131, 371-381.
6. Bloomston, M., Frankel, W.L., Petrocca, F., Volinia, S., Alder, H., Hagan, J.P., Liu, C.G., Bhatt, D., Taccioli, C., and Croce, C.M. (2007). MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901-1908.
7. Christensen, B.C., Avissar-Whiting, M., Ouellet, L.G., Butler, R.A., Nelson, H.H., McClean, M.D., Marsit, C.J., and Kelsey, K.T. (2010). Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin. Cancer Res. 16, 3713-3720.
8. Duan, R., Pak, C., and Jin, P. (2007). Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet. 16, 1124-1131.
9. Elton, T.S., Sansom, S.E., and Martin, M.M. (2010). Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: is There a MicroRNA Connection? Int. J. Hypertens 2010, 1-13.
10. Ezzedine, K., Lim, H.W., Suzuki, T. et al. (2012). Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 25, E1-E13.
11. Filipowicz, W., Bhattacharyya, S.N., and Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114.
12. Gao, L.B., Bai, P., Pan, X.M., Jia, J., Li, L.J., Liang, W.B., Tang, M., Zhang, L.S., Wei, Y.G., and Zhang, L. (2011). The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 125, 571-574.
13. Ghanem, G., and Fabrice, J. (2011). Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma. Mol. Oncol. 5, 150-155.
14. Guerra, L., Dellambra, E., Brescia, S., and Raskovic, D. (2010). Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr. Drug Metab. 11, 451-467.
15. Hu, Z., Chen, J., Tian, T. et al. (2008). Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118, 2600-2608.
16. Hu, Z., Liang, J., Wang, Z., Tian, T., Zhou, X., Chen, J., Miao, R., Wang, Y., Wang, X., and Shen, H. (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30, 79-84.
17. Jain, A., Mal, J., Mehndiratta, V., Chander, R., and Patra, S.K. (2011). Study of oxidative stress in vitiligo. Indian J. Clin. Biochem. 26, 78-81.
18. Jian, Z., Li, K., Liu, L., Zhang, Y., Zhou, Z., Li, C., and Gao, T. (2011). Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway. J. Invest. Dermatol. 131, 1420-1427.
19. Jimbow, K., Chen, H., Park, J.S., and Thomas, P.D. (2001). Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br. J. Dermatol. 144, 55-65.
20. Kemp, E.H., Waterman, E.A., Gawkrodger, D.J., Watson, P.F., and Weetman, A.P. (1998). Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br. J. Dermatol. 139, 798-805.
21. Khan, R., Gupta, S., and Sharma, A. (2012). Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-beta) in patients with vitiligo. J. Am. Acad. Dermatol. 66, 510-511.
22. Kobayashi, T., Imokawa, G., Bennett, D.C., and Hearing, V.J. (1998). Tyrosinase stabilization by Tyrp1 (the brown locus protein). J. Biol. Chem. 273, 31801-31805.
23. Luo, D., Chen, H., and Jimbow, K. (1994). Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1. Exp. Cell Res. 213, 231-241.
24. Majumder, P.P., Nordlund, J.J., and Nath, S.K. (1993). Pattern of familial aggregation of vitiligo. Arch. Dermatol. 129, 994-998.
25. Manga, P., Sheyn, D., Yang, F., Sarangarajan, R., and Boissy, R.E. (2006). A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: implications for vitiligo. Am. J. Pathol. 169, 1652-1662.
26. Mayenburg, J.V., Vogt, H.J., and Ziegelmayer, G. (1976). [Vitiligo in an pair of enzygotic twins]. Hautarzt 27, 426-431.
27. Osman, A. (2012). MicroRNAs in health and disease-basic science and clinical applications. Clin. Lab. 58, 393-402.
28. Permuth-Wey, J., Thompson, R.C., Burton Nabors, L., Olson, J.J., Browning, J.E., Madden, M.H., Ann Chen, Y., and Egan, K.M. (2011). A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J. Neurooncol. 105, 639-646.
29. Prcic, S., Duran, V., and Poljacki, M. (2002). [Vitiligo in childhood]. Med. Pregl. 55, 475-480.
30. Reich, D.E., Gabriel, S.B., and Altshuler, D. (2003). Quality and completeness of SNP databases. Nat. Genet. 33, 457-458.
31. Sayed, D., and Abdellatif, M. (2011). MicroRNAs in development and disease. Physiol. Rev. 91, 827-887.
32. Schallreuter, K.U., Elwary, S.M., Gibbons, N.C., Rokos, H., and Wood, J.M. (2004). Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem. Biophys. Res. Commun. 315, 502-508.
33. Schallreuter, K.U., Gibbons, N.C., Zothner, C., Elwary, S.M., Rokos, H., and Wood, J.M. (2006). Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo. Biochem. Biophys. Res. Commun. 349, 931-938.
34. Schallreuter, K.U., Rubsam, K., Gibbons, N.C., Maitland, D.J., Chavan, B., Zothner, C., Rokos, H., and Wood, J.M. (2008). Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo. J. Invest. Dermatol. 128, 808-815.
35. Smith, R.A., Jedlinski, D.J., Gabrovska, P.N., Weinstein, S.R., Haupt, L., and Griffiths, L.R. (2012). A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics 9, 115-118.
36. Spencer, J.D., Gibbons, N.C., Rokos, H., Peters, E.M., Wood, J.M., and Schallreuter, K.U. (2007). Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J. Invest. Dermatol. 127, 411-420.
37. Spritz, R.A. (2006). The genetics of generalized vitiligo and associated autoimmune diseases. J. Dermatol. Sci. 41, 3-10.
38. Tai, T., Eisinger, M., Ogata, S., and Lloyd, K.O. (1983). Glycoproteins as differentiation markers in human malignant melanoma and melanocytes. Cancer Res. 43, 2773-2779.
39. Vijayasaradhi, S., and Houghton, A.N. (1991). Purification of an autoantigenic 75-kDa human melanosomal glycoprotein. Int. J. Cancer 47, 298-303.
40. Wang, M., Ye, Y., Qian, H., Song, Z., Jia, X., Zhang, Z., Zhou, J., and Ni, C. (2010). Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis. J. Hum. Genet. 55, 13-17.
41. Xing, J., Wan, S., Zhou, F. et al. (2012). Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 21, 217-227.
42. Xu, J., Hu, Z., Xu, Z. et al. (2009). Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum. Mutat. 30, 1231-1236.
43. Yang, W., Chendrimada, T.P., Wang, Q., Higuchi, M., Seeburg, P.H., Shiekhattar, R., and Nishikura, K. (2006). Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13, 13-21.
44. Yoon, K.A., Yoon, H., Park, S., Jang, H.J., Zo, J.I., Lee, H.S., and Lee, J.S. (2012). The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 144, 794-807.
45. Zhang, X.J., Liu, J.B., Gui, J.P. et al. (2004). Characteristics of genetic epidemiology and genetic models for vitiligo. J. Am. Acad. Dermatol. 51, 383-390.